↓ Skip to main content

Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending…

Overview of attention for article published in Respiratory Research, September 2020
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator
Published in
Respiratory Research, September 2020
DOI 10.1186/s12931-020-01470-5
Pubmed ID
Authors

Eulalia Jimenez, Carol Astbury, Muna Albayaty, Ulrika Wählby-Hamrén, Beatriz Seoane, Cristina Villarroel, Helena Pujol, Maria Jesus Bermejo, Ajay Aggarwal, Ioannis Psallidas

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 20%
Student > Ph. D. Student 2 13%
Other 1 7%
Lecturer 1 7%
Student > Doctoral Student 1 7%
Other 3 20%
Unknown 4 27%
Readers by discipline Count As %
Medicine and Dentistry 6 40%
Pharmacology, Toxicology and Pharmaceutical Science 2 13%
Social Sciences 2 13%
Chemical Engineering 1 7%
Agricultural and Biological Sciences 1 7%
Other 0 0%
Unknown 3 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2020.
All research outputs
#14,546,210
of 18,881,749 outputs
Outputs from Respiratory Research
#1,903
of 2,354 outputs
Outputs of similar age
#218,248
of 312,376 outputs
Outputs of similar age from Respiratory Research
#2
of 3 outputs
Altmetric has tracked 18,881,749 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,354 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 312,376 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.